Lean Six Sigma Progress and Operational Excellence in Pharmaceutical, Biotech and Medical Device Organizations

NEW YORK & SAN DIEGO--(BUSINESS WIRE)-- Due to global competition, reduced patent protection, increased R&D costs and heightened regulatory scrutiny, pharmaceutical, biotech and medical device industries are forced to identify the most effective ways to reduce spending and increase quality. Lean Six Sigma, as proven in many other industries, presents opportunities for pharmaceutical organizations to boost operational efficiency, improve quality and facilitate compliance.

In a recent interview with Pharma IQ, Paul Nelson, Operational Excellence Leader at Shire Pharmaceuticals, spoke about Lean Six Sigma practices and approaches that are being adopted from other industries and incorporated into biotechnology processes. He states: “[F]or me, I think the most exciting adoption of practice is in the area of process understanding and product characterization. It is a fantastic example of using the Six Sigma concepts from mature industries and applying them to newer areas in biotechnology… Our industry has lagged in that area but I have seen some good progress recently.”

Mr. Nelson goes on to discuss LSS trends and the tools or programs Shire Pharmaceuticals has found effective for sustaining excellence. The full Q&A interview is available on the Pharma IQ website.

Mr. Nelson will be joined by Genentech, Philips Healthcare, Pfizer Worldwide R&D, Bayer Healthcare, Cardinal Health, Boehringer Ingelheim and others at Pharma IQ’s 12th Annual Lean Six Sigma for Pharmaceutical, Biotech and Medical Device Excellence to foster a culture of continuous improvement. (www.LSSPharma.com)

The event, being held July 20-22, 2011 in San Diego, CA discusses innovative solutions for both manufacturing and non-manufacturing roles on more than 20 different topics and areas, including:

  • Addressing the next steps for mature Six Sigma & Lean projects and programs
  • Utilizing Lean Six Sigma in research & development (R&D), sales & marketing, information technology (IT), regulatory compliance, administration and transactions
  • Eliminating silos across functional lines
  • Improving supplier relationships through effective supplier integration
  • Achieving sustainability and success through knowledge & change management
  • Fostering a culture of continuous improvement from the top down and ensuring leadership buy-in

For more information on the 12th Annual Lean Six Sigma for Pharmaceutical, Biotech and Medical Device Excellence event, visit www.LSSPharma.com or contact Claudia Rubino, Conference Director, at [email protected].

About IQPC

IQPC (www.iqpc.com) provides business executives with tailored practical conferences, large-scale events, topical seminars and in-house training programs. Producing over 1,500 events annually around the world, IQPC continues to grow and has offices in cities across six continents including: Berlin, Dubai, London, New York, Sao Paulo, Singapore, Sydney, and Toronto.



CONTACT:

IQPC
Abby Lombardi, +1 212-885-2660
F: +1 888-231-7864
www.iqpc.com

KEYWORDS:   United States  North America  California  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Medical Devices  Pharmaceutical  Other Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

LianBio aims to bring much-needed new drugs to China and serve as a partner for U.S. biotechs looking to expand into Asia.

Despite the setback, Fulcrum hailed the data as “very encouraging,” zeroing in on results from a pre-specified sensitivity analysis to make its case.

Bayer has struck a $425 million upfront deal to buy KaNDy in the belief its treatment for menopause-related hot flashes has blockbuster potential.